Liposarcomas are a rare type of malignancy with a very heterogeneous morphological appearance and clinical course. The therapeutic approach is based on histopathological classification and is ...

June 25, 2007 — A novel marine-derived alkaloid called trabectedin has shown antitumor activity in patients with myxoid liposarcoma, according to a report published online June 21 in Lancet Oncology. ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — A single infusion of letetresgene autoleucel demonstrated antitumor activity among patients with ...

Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials In this pilot study, we assessed the ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Letetresgene autoleucel (lete-cel) showed a 42% response rate in a phase 2 trial for synovial sarcoma and myxoid/round cell liposarcoma. The trial included 64 patients, with 41% response in synovial ...

To the Editor: In our opinion, the mass described as a myxoid liposarcoma and shown in the January 29 Images in Clinical Medicine 1 is not an example of that entity but, rather, an atypical lipomatous ...

deadly type of soft-tissue cancer and holds promise for ovarian cancer as drug does not cause hair loss or diarrhea. Advanced clinical trials are under way for myxoid liposarcoma -- and for ovarian ...